Nathalie Compagnone
Chief Executive Officer at Innovative Concepts in Drug Development SAS
Nathalie Compagnone active positions
| Companies | Position | Start | End |
|---|---|---|---|
Innovative Concepts in Drug Development SAS
 Innovative Concepts in Drug Development SAS BiotechnologyHealth Technology Innovative Concepts in Drug Development SAS develops and provides innovative proprietary screening platforms to the pharmaceutical development sector. The company was founded by Natahlie Compagnone in 2007 and is headquartered in Gemenos, France. | Chief Executive Officer | 2006-12-31 | - |
| Chief Tech/Sci/R&D Officer | 2006-12-31 | - | |
| Founder | 2006-12-31 | - |
Career history of Nathalie Compagnone
Former positions of Nathalie Compagnone
| Companies | Position | Start | End |
|---|---|---|---|
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Corporate Officer/Principal | 2003-12-31 | - |
| The University of California, San Francisco | Corporate Officer/Principal | 1998-12-31 | - |
Training of Nathalie Compagnone
| Université de Franche-Comté | Undergraduate Degree |
| Rutgers State University of New Jersey | Masters Business Admin |
Statistics
International
| France | 5 |
| United States | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Health Technology |
Innovative Concepts in Drug Development SAS
Innovative Concepts in Drug Development SAS BiotechnologyHealth Technology Innovative Concepts in Drug Development SAS develops and provides innovative proprietary screening platforms to the pharmaceutical development sector. The company was founded by Natahlie Compagnone in 2007 and is headquartered in Gemenos, France. | Health Technology |
- Stock Market
- Insiders
- Nathalie Compagnone
- Experience
